Doctors, Drug Companies, and Gifts

JAMA: The Journal of the American Medical Association

Volumn 262, Issue 24, 1989, Pages 3448-3451

  Chren, Mary Margaret ^a   Landefeld, C Seth ^a   Murray, Thomas H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOCTOR PATIENT RELATION; DRUG INDUSTRY; ECONOMIC ASPECT; FEE; MEDICAL ETHICS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

CLINICAL APPROACH/SOURCE; GIFTS; HEALTH CARE AND PUBLIC HEALTH; INCENTIVES; JUSTICE; PROFESSIONAL ORGANIZATIONS; PROFESSIONAL PATIENT RELATIONSHIP; REMUNERATION; STANDARDS; UNITED STATES;

DRUG INDUSTRY; ETHICS, MEDICAL; INTERPROFESSIONAL RELATIONS; MORAL OBLIGATIONS; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; ROLE; UNITED STATES;

EID: 0024826182     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1989.03430240084035     Document Type: Article

References (27)

1. Graves J. Frequent-flyer programs for drug prescribing. N Engl J Med. 1987;317:252.
2. Goldfinger SE. A matter of influence. N Engl J Med. 1987;316:1408-1409.
3. Smith R. Doctors and the drug industry: too close for comfort. Br Med J. 1986;293:905-906.
4. Shaughnessy AF. Drug promotion in a family medicine training center. JAMA. 1988;260:926.
5. Rawlins MD. Doctors and the drug makers. Lancet. 1984;2:276-278.
6. ‘Opren scandal.’ Lancet. 1983;1:219-220.
7. Fakes RW. Doctors and the drug industry. Br Med J. 1986;293:1170-1171.
8. Katz RA. Unhook me. J Am Acad Dermatol. 1987;17:865-866.
9. The relationship between physicians and the pharmaceutical industry: a report of the Royal College of Physicians. J R Coll Physicians Lond. 1986;20:235-242.
10. Relman AS. Dealing with conflicts of interest. N Engl J Med. 1985;313:749-751.
11. Graboys TB. Conflicts of interest in the management of silent ischemia. JAMA. 1989;261:2016-2017.
12. Healy B, Campeau L, Gray R, et al. Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med. 1989;320:949-951.
13. Relman AS. Economic incentives in clinical investigation. N Engl J Med. 1989;320:933-934.
14. Chotiner G. Response. J Am Acad Dermatol. 1987;17:866.
15. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.
16. Mauss M; Cunnison I, trans. The Gift: Forms and Functions of Exchange in Archaic Societies. New York, NY: WW Norton & Co Inc; 1967.
17. Murray TH. Gifts of the body and the needs of strangers. Hastings Cent Rep. 1987;17:30-38.
18. Titmuss RM. The Gift Relationship. New York, NY: Pantheon Books Inc; 1971.
19. Camenisch PF. Gift and gratitude in ethics. J Religious Ethics. 1981;9:1-33.
20. Emerson RW. Gifts. In: Essays of Ralph Waldo Emerson. Norwalk, Conn: Easton Press; 1979:211-214. Series II.
21. Jonsen AR. Watching the doctor. N Engl J Med. 1983;308:1531-1535.
22. Ad Hoc Committee on Medical Ethics, American College of Physicians. American College of Physicians ethics manual, part 1: history of medical ethics, the physician and the patient, the physician’s relationship to other physicians, the physician and society. Ann Intern Med. 1984;101:129-137.
23. Murray TH. Divided loyalties for physicians: social context and moral problems. Soc Sci Med. 1986;23:827-832.
24. Laczniak GR, Murphy PE. Marketing Ethics: Guidelines for Managers. Lexington, Mass: Lexington Books; 1985.
25. Drugs and devices: prescribing. Current Opinions of the Council on Ethical and Judicial Affairs of the American Medical Association—1986. Chicago, Ill: American Medical Association; 1986: sect 8.06.
26. American Medical Association House of Delegates. Substitute Resolution 172—Condemnation of Certain Practices of Pharmaceutical Companies. Chicago, Ill: American Medical Association; 1987.
27. Bricker EM. Industrial marketing and medical ethics. N Engl J Med. 1989;320:1690-1692.